Mark LaRocco
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 14
- Endocrinology top 2%
- Vibrio bacteria research studies 6
- Escherichia coli research studies 5
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 8
- Clostridium difficile and Clostridium perfringens research 6
-
- Antibiotics Pharmacokinetics and Efficacy 6
-
- Bacterial biofilms and quorum sensing 5
-
- Bacterial Identification and Susceptibility Testing 5
- Co-authors
- Layne O. GentryMargaret F. PriceKevin W. GareyLiliana F. RodriguezSusan M. HoustonNorbert RunkelFrank G. MoodyGregory S. Smith
- Cited by
- Molecular MedicineApplied Microbiology and BiotechnologyCritical Care and Intensive Care Medicine
- Journals
- Journal of Clinical Microbiology (8 papers)Diagnostic Microbiology and Infectious Disease (6 papers)Antimicrobial Agents and Chemotherapy (4 papers)
- Partner nations
- United StatesNetherlandsIsrael
In The Last Decade
Mark LaRocco
61 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 121
- Molecular Medicine 386
- Applied Microbiology and Biotechnology 131
- Critical Care and Intensive Care Medicine 250
- Endocrinology 174
- Infectious Diseases 606
Countries citing papers authored by Mark LaRocco
This map shows the geographic impact of Mark LaRocco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark LaRocco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark LaRocco more than expected).
Fields of papers citing papers by Mark LaRocco
This network shows the impact of papers produced by Mark LaRocco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark LaRocco. The network helps show where Mark LaRocco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark LaRocco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2009 | 6 | |
| 3 | 2008 | 92 | |
| 4 | 2007 | 37 | |
| 5 | 2006 | 19 | |
| 6 | 2006 | 69 | |
| 7 | 2000 | 10 | |
| 8 | 1999 | 16 | |
| 9 | 1998 | 31 | |
| 10 | 1994 | 81 | |
| 11 | 1993 | 61 | |
| 12 | 1992 | 5 | |
| 13 | 1992 | 3 | |
| 14 | 1992 | 30 | |
| 15 | 1992 | 12 | |
| 16 | 1991 | 1 | |
| 17 | 1991 | 175 | |
| 18 | 1990 | 1 | |
| 19 | 1987 | 16 | |
| 20 | 1987 | 5 |
About Mark LaRocco
Mark LaRocco is a scholar working on Molecular Medicine, Microbiology, Endocrinology, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 61 papers that have together received 1.9k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (14 papers), Antifungal resistance and susceptibility (8 papers), Vibrio bacteria research studies (6 papers), Clostridium difficile and Clostridium perfringens research (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Bacterial biofilms and quorum sensing (5 papers), Escherichia coli research studies (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). The work is most often cited by research in Molecular Medicine (386 citations), Applied Microbiology and Biotechnology (131 citations), Critical Care and Intensive Care Medicine (250 citations), Endocrinology (174 citations) and Infectious Diseases (606 citations). Mark LaRocco has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include Layne O. Gentry, Margaret F. Price, Kevin W. Garey, Liliana F. Rodriguez, Susan M. Houston, Norbert Runkel, Frank G. Moody, Gregory S. Smith, Thomas A. Miller and Vincent H. Tam. Their work appears in journals such as Journal of Clinical Microbiology, Diagnostic Microbiology and Infectious Disease, Antimicrobial Agents and Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and Clinical Microbiology Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.